{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-237218","form_type":"8-K","ticker":"CDNA","cik":"0001217234","company_name":"CareDx, Inc.","filed_at":"2024-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.886215+00:00","generated_at":"2026-05-30T14:25:11.370309+00:00","sec_items":["2.02","9.01","7.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CareDx reports preliminary Q3 revenue of $82-83M, up 23% YoY; testing volume rises 16%","bullets":["Preliminary Q3 2024 revenue $82-83M, up ~23% YoY; testing services $60-61M (+26%).","Testing volume ~44,600 tests, up ~16% YoY; includes $1.2M from prior quarters.","Patient & Digital Solutions rev ~$11.9M (+20%); Products rev ~$10.2M (+7%).","Cash and marketable securities ~$240M, no debt; strong balance sheet.","Full Q3 results to be reported on November 4, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-237218","json":"https://secwatch.observer/filing/0001193125-24-237218.json","markdown":"https://secwatch.observer/filing/0001193125-24-237218.md","text":"https://secwatch.observer/filing/0001193125-24-237218.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1217234/000119312524237218/0001193125-24-237218-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1217234/000119312524237218/d889373d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T14:25:11.370309+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}